Log In
Print
BCIQ
Print
Print this Print this
 

Urelumab (BMS-663513)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionMAb agonist of tumor necrosis factor (TNF) receptor superfamily member 9 (TNFRSF9; 4-1BB, CD137)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 9 (TNFRSF9) (4-1BB) (CD137)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner

Ono Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today